Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares stood at 1.17 million during the last session, with the company’s beta value hitting 0.15. At the close of
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) has a beta value of 0.29 and has seen 1.19 million shares traded in the last trading session. The company, currently
During the last session, Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares were 1.27 million, with the beta value of the company hitting 0.19. At the end
In the last trading session, 1.26 million shares of the Phathom Pharmaceuticals Inc (NASDAQ:PHAT) were traded, and its beta was 0.29. Most recently the company’s
Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares stood at 1.28 million during the last session, with the company’s beta value hitting 0.19. At the close of
Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares stood at 1.15 million during the last session, with the company’s beta value hitting 0.37. At the close of
In last trading session, Phathom Pharmaceuticals Inc (NASDAQ:PHAT) saw 0.8 million shares changing hands with its beta currently measuring 0.18. Company’s recent per share price
In last trading session, Phathom Pharmaceuticals Inc (NASDAQ:PHAT) saw 1.23 million shares changing hands with its beta currently measuring 0.11. Company’s recent per share price
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) has a beta value of 0.31 and has seen 1.47 million shares traded in the last trading session. The company, currently
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) has a beta value of 0.34 and has seen 1.07 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
